DAPK1 and Parkinson disease: DAPK1 knockdown exerts rapid antidepressant-like effects, and DAPK1 ablation in dopaminergic neurons reverses abnormalities in mouse Parkinson’s disease (PD) models after long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) exposure [34,35].